CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.

Saved in:
Bibliographic Details
Title: CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.
Authors: Hsu, Andrew1,2 (AUTHOR), Kurt, Habibe3 (AUTHOR), Zayac, Adam S.1 (AUTHOR), Olszewski, Adam J.1,2 (AUTHOR)
Source: Leukemia & Lymphoma. Jan2022, Vol. 63 Issue 1, p31-42. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 154569789
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Hsu%2C+Andrew%22">Hsu, Andrew</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kurt%2C+Habibe%22">Kurt, Habibe</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zayac%2C+Adam+S%2E%22">Zayac, Adam S.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Olszewski%2C+Adam+J%2E%22">Olszewski, Adam J.</searchLink><relatesTo>1,2</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Leukemia+%26+Lymphoma%22">Leukemia & Lymphoma</searchLink>. Jan2022, Vol. 63 Issue 1, p31-42. 12p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=154569789
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1080/10428194.2021.1973670
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 31
    Titles:
      – TitleFull: CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Hsu, Andrew
      – PersonEntity:
          Name:
            NameFull: Kurt, Habibe
      – PersonEntity:
          Name:
            NameFull: Zayac, Adam S.
      – PersonEntity:
          Name:
            NameFull: Olszewski, Adam J.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2022
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 10428194
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Leukemia & Lymphoma
              Type: main
ResultId 1